{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Drug discovery", "Hepatitis B", "Medicinal plants", "Natural products"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34631974", "DateRevised": {"Year": "2022", "Month": "09", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "07", "Day": "14"}], "Language": ["eng"], "ELocationID": ["10.1007/s13337-021-00714-2"], "Journal": {"ISSN": "2347-3584", "JournalIssue": {"Volume": "32", "Issue": "3", "PubDate": {"Year": "2021", "Month": "Sep"}}, "Title": "Virusdisease", "ISOAbbreviation": "Virusdisease"}, "ArticleTitle": "Anti-hepatitis B activities of Myanmar medicinal plants: a narrative review of current evidence.", "Pagination": {"StartPage": "446", "EndPage": "466", "MedlinePgn": "446-466"}, "Abstract": {"AbstractText": ["Hepatitis B is one of the major burdens for health services and is the leading cause of morbidity and mortality from cirrhosis of liver and hepatocellular carcinoma. Current treatment strategies using nucleos(t)ide analogue reverse-transcriptase inhibitors or interferons are targeted for the long-term suppression of hepatitis B DNA. However, functional cure of hepatitis B infection (HBsAg clearance) was difficult to attain with such treatments. Therefore, new treatment strategies or innovative treatments are urgently needed. The new treatments should focus on the potential therapeutic targets such as covalently closed circular DNA which may be important for the HBsAg clearance. Plant based medicines have been used in different traditional medicine practices and these natural products/compounds serve as a good source of information or clues for use in drug discovery and design. Many natural products were found to be effective against hepatitis B virus and some even have better therapeutic activities than currently used compounds. This review summarizes the current evidence of Myanmar medicinal plants in basic and clinical research which shows promising potential for the development of novel therapeutic agents for the treatment of hepatitis B."], "CopyrightInformation": "\u00a9 Indian Virological Society 2021."}, "AuthorList": [{"Identifier": ["0000-0003-0852-5218"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "FAME Pharmaceuticals Industry Co., Ltd., No. 20, Mingyi Mahar Min Gaung Road, Industrial Zone (3), Hlaing Thar Yar City of Industry, Yangon, 11401 Myanmar."}], "LastName": "Linn", "ForeName": "Ye Htut", "Initials": "YH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "FAME Pharmaceuticals Industry Co., Ltd., No. 20, Mingyi Mahar Min Gaung Road, Industrial Zone (3), Hlaing Thar Yar City of Industry, Yangon, 11401 Myanmar."}], "LastName": "Ei", "ForeName": "Win Win", "Initials": "WW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "FAME Pharmaceuticals Industry Co., Ltd., No. 20, Mingyi Mahar Min Gaung Road, Industrial Zone (3), Hlaing Thar Yar City of Industry, Yangon, 11401 Myanmar."}], "LastName": "Myint", "ForeName": "Lwin Mon Mon", "Initials": "LMM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "FAME Pharmaceuticals Industry Co., Ltd., No. 20, Mingyi Mahar Min Gaung Road, Industrial Zone (3), Hlaing Thar Yar City of Industry, Yangon, 11401 Myanmar."}], "LastName": "Lwin", "ForeName": "Khin Maung", "Initials": "KM"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "India", "MedlineTA": "Virusdisease", "NlmUniqueID": "101624144", "ISSNLinking": "2347-3584"}, "CoiStatement": "Conflict of interestAuthors declare that they have no conflict of interest. We declared that this manuscript/data has not been published or currently under review for publication elsewhere."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Arbab AH, Parvez MK, Al-Dosari MS, et al. In vitro evaluation of novel antiviral activities of 60 medicinal plants extracts against hepatitis B virus. Exp Ther Med. 2017;14(1):626\u2013634. doi: 10.3892/etm.2017.4530.", "ArticleIdList": ["10.3892/etm.2017.4530", "PMC5488430", "28672977"]}, {"Citation": "Berk L, de Man RA, Schalm SW, et al. Beneficial effects of Phyllanthus amarus for chronic hepatitis B, not confirmed. J Hepatol. 1991;12(3):405\u2013406. doi: 10.1016/0168-8278(91)90850-B.", "ArticleIdList": ["10.1016/0168-8278(91)90850-B", "1940272"]}, {"Citation": "Chan HLY, Sung JJY, Fong WF, et al. Double-blinded placebo-controlled study of Phyllanthus urinaris for the treatment of chronic hepatitis B. Aliment Pharmacol Ther. 2003;18(3):339\u2013345. doi: 10.1046/j.1365-2036.2003.01671.x.", "ArticleIdList": ["10.1046/j.1365-2036.2003.01671.x", "12895219"]}, {"Citation": "Chang J, Liu H, Wang K, et al. Ethanol extract of Polygonum cuspidatum inhibits hepatitis B virus in a stable HBV-producing cell line. Antivir Res. 2005;66(1):29\u201334. doi: 10.1016/j.antiviral.2004.12.006.", "ArticleIdList": ["10.1016/j.antiviral.2004.12.006", "15781129"]}, {"Citation": "Chen H, Ma YB, Huang XY, et al. Synthesis, structure\u2013activity relationships and biological evaluation of dehydroandrographolide and andrographolide derivatives as novel anti-hepatitis B virus agents. Bioorg Med Chem Lett. 2014;24(10):2353\u20132359. doi: 10.1016/j.bmcl.2014.03.060.", "ArticleIdList": ["10.1016/j.bmcl.2014.03.060", "24731274"]}, {"Citation": "Chiang LC, Ng LT, Cheng PW, et al. Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin Exp Pharmacol Physiol. 2005;32(10):811\u2013816. doi: 10.1111/j.1440-1681.2005.04270.x.", "ArticleIdList": ["10.1111/j.1440-1681.2005.04270.x", "16173941"]}, {"Citation": "Chung TH, Kim JC, Kim MK, et al. Investigation of Korean plant extracts for potential phytotherapeutic agents against B-virus hepatitis. Phytother Res. 1995;9(6):429\u2013434. doi: 10.1002/ptr.2650090609.", "ArticleIdList": ["10.1002/ptr.2650090609"]}, {"Citation": "Cornberg M, Wong VWS, Locarnini S, et al. The role of quantitative hepatitis B surface antigen revisited. J Hepatol. 2017;66(2):398\u2013411. doi: 10.1016/j.jhep.2016.08.009.", "ArticleIdList": ["10.1016/j.jhep.2016.08.009", "27575311"]}, {"Citation": "Das BK, Shohel M, Pavel AM, et al. Anti hepatitis B viral activity of Phyllanthus reticulatus. Bangladesh Pharm J. 2011;14(1):4."}, {"Citation": "Department of Traditional Medicine. Medicinal Plants of Myanmar (Vol. 2). Ministry of Health. Naypyitaw; 2007."}, {"Citation": "Department of Traditional Medicine. Myanmar Herbal Pharmacopoeia (Vol. 2). Ministry of Health and Sports. Naypyitaw; 2018."}, {"Citation": "Eisenburg J. Treatment of chronic hepatitis B. Part 2: effect of glycyrrhizic acid on the course of illness. Fortschr Med. 1992;110(21):395\u2013398.", "ArticleIdList": ["1516877"]}, {"Citation": "Fan JM, Zhang Q, Xu J, et al. Inhibition on Hepatitis B virus in vitro of recombinant MAP30 from bitter melon. Mol Biol Rep. 2009;36(2):381\u2013388. doi: 10.1007/s11033-007-9191-2.", "ArticleIdList": ["10.1007/s11033-007-9191-2", "18058255"]}, {"Citation": "Feustel S, Ay\u00f3n-P\u00e9rez F, Sandoval-Rodriguez A, et al. Protective effects of Moringa oleifera on HBV Genotypes C and H transiently transfected Huh7 cells. J Immunol Res. 2017;2017:1\u20139. doi: 10.1155/2017/6063850.", "ArticleIdList": ["10.1155/2017/6063850", "PMC5682080", "29214184"]}, {"Citation": "Geng CA, Ma YB, Zhang XM, et al. Mulberrofuran G and Isomulberrofuran G from Morus alba L.: Anti-hepatitis B virus activity and mass spectrometric fragmentation. J Agric Food Chem. 2012;60(33):8197\u20138202. doi: 10.1021/jf302639b.", "ArticleIdList": ["10.1021/jf302639b", "22835135"]}, {"Citation": "He W, Li LX, Liao QJ, et al. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication\u2014inducible cell line. World J Gastroenterol. 2011;17(11):1507\u20131514. doi: 10.3748/wjg.v17.i11.1507.", "ArticleIdList": ["10.3748/wjg.v17.i11.1507", "PMC3070027", "21472112"]}, {"Citation": "Ho LK, Don MJ, Chen HC, et al. Inhibition of hepatitis b surface antigen secretion on human Hepatoma Cells. Components from Rubia cordifolia. J Nat Prod. 1996;59(3):330\u2013333. doi: 10.1021/np960200h.", "ArticleIdList": ["10.1021/np960200h", "8882438"]}, {"Citation": "Huang HC, Tao MH, Hung TM, et al. (\u2212)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes. Antivir Res. 2014;111:100\u2013111. doi: 10.1016/j.antiviral.2014.09.009.", "ArticleIdList": ["10.1016/j.antiviral.2014.09.009", "25260897"]}, {"Citation": "Indrasetiawan P, Aoki-Utsubo C, Hanafi M, et al. Antiviral activity of Cananga odorata against hepatitis B virus. Kobe J Med Sci. 2019;65(2):E71\u201379.", "ArticleIdList": ["PMC7012192", "31956259"]}, {"Citation": "Jacob JR, Mansfield K, You JE, et al. Natural iminosugar derivatives of 1-Deoxynojirimycin inhibit glycosylation of hepatitis viral envelope proteins. J Microbiol. 2007;45(5):431\u2013440.", "ArticleIdList": ["17978803"]}, {"Citation": "Jeng JE, Tsai MF, Tsai HR, et al. Impact of Chronic Hepatitis B and Hepatitis C on adverse hepatic fibrosis in hepatocellular carcinoma related to betel quid chewing. Asian Pac J Cancer Prev. 2014;15(2):637\u2013642. doi: 10.7314/APJCP.2014.15.2.637.", "ArticleIdList": ["10.7314/APJCP.2014.15.2.637", "24568470"]}, {"Citation": "Jiang ZY, Liu WF, Zhang XM, et al. Anti-HBV active constituents from Piper longum. Bioorg Med Chem Lett. 2013;23(7):2123\u20132127. doi: 10.1016/j.bmcl.2013.01.118.", "ArticleIdList": ["10.1016/j.bmcl.2013.01.118", "23434420"]}, {"Citation": "Jiang ZY, Yu YJ, Huang CG, et al. Icetexane Diterpenoids from Perovskia atriplicifolia. Planta Med. 2015;81(03):241\u2013246. doi: 10.1055/s-0034-1396151.", "ArticleIdList": ["10.1055/s-0034-1396151", "25611748"]}, {"Citation": "Jung J, Kim NK, Park S, et al. Inhibitory effect of Phyllanthus urinaria L. extract on the replication of lamivudine-resistant hepatitis virus in vitro. BMC Complement Altern Med. 2015;15(1):255. doi: 10.1186/s12906-015-0792-3.", "ArticleIdList": ["10.1186/s12906-015-0792-3", "PMC4518506", "26220282"]}, {"Citation": "Kim TG, Kang SY, Jung KK, et al. Antiviral activities of extracts isolated from Terminalis chebula retz, Sanguisorba officinalis L, Rubus coreanus miq and Rheum palmatum L against hepatitis B virus. Phytother Res. 2001;15(8):718\u2013720. doi: 10.1002/ptr.832.", "ArticleIdList": ["10.1002/ptr.832", "11746867"]}, {"Citation": "Kim HJ, Yoo HS, Kim JC, et al. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication. J Ethnopharmacol. 2009;124(2):189\u2013196. doi: 10.1016/j.jep.2009.04.046.", "ArticleIdList": ["10.1016/j.jep.2009.04.046", "19409970"]}, {"Citation": "Kress WJ. A checklist of the trees, shrubs, herbs, and climbers of Myanmar: Vol. Contributions from the United States National Herbarium. Department of Systematic Biology\u2014Botany, National Museum of Natural History; 2003."}, {"Citation": "Lai YH, Sun CP, Huang HC, et al. Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice. BMC Complement Altern Med. 2018;18(1):248. doi: 10.1186/s12906-018-2316-4.", "ArticleIdList": ["10.1186/s12906-018-2316-4", "PMC6127945", "30189898"]}, {"Citation": "Lampertico P, Agarwal K, Berg T, et al. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u2013398. doi: 10.1016/j.jhep.2017.03.021.", "ArticleIdList": ["10.1016/j.jhep.2017.03.021", "28427875"]}, {"Citation": "Lee CD, Ott M, Thyagarajan SP, et al. Phyllanthus amarus down-regulates hepatitis B virus mRNA transcription and replication. Eur J Clin Invest. 1996;26(12):1069\u20131076. doi: 10.1046/j.1365-2362.1996.410595.x.", "ArticleIdList": ["10.1046/j.1365-2362.1996.410595.x", "9013081"]}, {"Citation": "Lee SJ, Lee HK, Jung MK, et al. In vitro antiviral activity of 1,2,3,4,6-Penta-O-galloyl-b-D-glucose against hepatitis B virus. Biol Pharm Bull. 2006;29(10):2131\u20132134. doi: 10.1248/bpb.29.2131.", "ArticleIdList": ["10.1248/bpb.29.2131", "17015965"]}, {"Citation": "Leelarasamee A, Trakulsomboon S, Maunwongyathi P, et al. Failure of Phyllanthus amarus to eradicate hepatitis B surface antigen from symptomless carriers. Lancet. 1990;335(8705):1600\u20131601. doi: 10.1016/0140-6736(90)91436-E.", "ArticleIdList": ["10.1016/0140-6736(90)91436-E", "1972525"]}, {"Citation": "Liu T, Zhao J, Li H, et al. Evaluation on anti-hepatitis viral activity of Vitis vinifer L. Molecules. 2010;15(10):7415\u20137422. doi: 10.3390/molecules15107415.", "ArticleIdList": ["10.3390/molecules15107415", "PMC6259095", "20966882"]}, {"Citation": "Lv JJ, Wang YF, Zhang JM, et al. Anti-hepatitis B virus activities and absolute configurations of sesquiterpenoid glycosides from Phyllanthus emblica. Org Biomol Chem. 2014;12(43):8764\u20138774. doi: 10.1039/C4OB01196A.", "ArticleIdList": ["10.1039/C4OB01196A", "25268491"]}, {"Citation": "Lv JJ, Yu S, Wang YF, et al. Anti-Hepatitis B virus Norbisabolane Sesquiterpenoids from Phyllanthus acidus and the establishment of their absolute configurations using theoretical calculations. J Org Chem. 2014;79(12):5432\u20135447. doi: 10.1021/jo5004604.", "ArticleIdList": ["10.1021/jo5004604", "24824117"]}, {"Citation": "Lwin KM, Lwin MKT. Medicinal plant list of Myanmar. 2. Yangon: FAME Publishing House; 2015."}, {"Citation": "Lwin AA, Aye KS, Htun MM, et al. Sero-prevalence of Hepatitis B and C viral infections in Myanmar: national and regional survey in 2015. Myanmar Health Sci Res J. 2017;29(3):167\u2013175."}, {"Citation": "Matsuo K, Takenaka K, Shimomura H, et al. Lamivudine and Glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with Non-Hodgkin Lymphoma. Leuk Lymphoma. 2001;41(1\u20132):191\u2013195. doi: 10.3109/10428190109057970.", "ArticleIdList": ["10.3109/10428190109057970", "11342373"]}, {"Citation": "Mohan K, Paramasivam R, Chandran P, et al. Inhibition of hepatitis B virus DNA polymerase and modulation of TH1 & TH2 cytokine secretion by three Indian medicinal plants and its correlation with antiviral properties. J Pharm Res. 2011;4(4):1044\u20131046."}, {"Citation": "Moraleda G, Wu TT, Jilbert AR, et al. Inhibition of duck hepatitis B virus replication by hypericin. Antivir Res. 1993;20(3):235\u2013247. doi: 10.1016/0166-3542(93)90023-C.", "ArticleIdList": ["10.1016/0166-3542(93)90023-C", "8470884"]}, {"Citation": "Mouler Rechtman M, Har-Noy O, Bar-Yishay I, et al. Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1\u03b1. FEBS Lett. 2010;584(11):2485\u20132490. doi: 10.1016/j.febslet.2010.04.067.", "ArticleIdList": ["10.1016/j.febslet.2010.04.067", "20434445"]}, {"Citation": "Munshi A, Mehrotra R, Ramesh R, et al. Evaluation of anti-hepadnavirus activity of Phyllanthus amarus and Phyllanthus maderaspatensis in duck hepatitis b virus carrier Pekin ducks. J Med Virol. 1993;41(4):275\u2013281. doi: 10.1002/jmv.1890410404.", "ArticleIdList": ["10.1002/jmv.1890410404", "8106861"]}, {"Citation": "Murray PR, Rosenthal KS, Pfaller MA. Medical microbiology (8th edition) Amsterdam: Elsevier; 2016."}, {"Citation": "Niu J, Wang Y, Qiao M, et al. Effect of Phyllanthus amarus on duck hepatitis B virus replication in vivo. J Med Virol. 1990;32(4):212\u2013218. doi: 10.1002/jmv.1890320404.", "ArticleIdList": ["10.1002/jmv.1890320404", "2081970"]}, {"Citation": "Ott M, Thyagarajan SP, Gupta S. Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors. Eur J Clin Invest. 1997;27(11):908\u2013915. doi: 10.1046/j.1365-2362.1997.2020749.x.", "ArticleIdList": ["10.1046/j.1365-2362.1997.2020749.x", "9395786"]}, {"Citation": "Pang R, Tao J, Zhang S, et al. In vitro anti-hepatitis B virus effect of Hypericum perforatum L. J Huazhong Univ Sci Technol Med Sci. 2010;30(1):98\u2013102. doi: 10.1007/s11596-010-0118-0.", "ArticleIdList": ["10.1007/s11596-010-0118-0", "20155464"]}, {"Citation": "Pang J, Zhao K, Wang J, et al. Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro. J Zhejiang Univ Sci B. 2014;15(6):533\u2013539. doi: 10.1631/jzus.B1300307.", "ArticleIdList": ["10.1631/jzus.B1300307", "PMC4116858", "24903990"]}, {"Citation": "Parvez MK, Al-Dosari MS, Alam P, et al. The anti-hepatitis B virus therapeutic potential of anthraquinones derived from Aloe vera. Phytother Res. 2019;33(11):2960\u20132970. doi: 10.1002/ptr.6471.", "ArticleIdList": ["10.1002/ptr.6471", "31410907"]}, {"Citation": "Pei S, Zhang Y, Xu H, et al. Inhibition of the Replication of Hepatitis B Virus in Vitro by Pu-erh Tea Extracts. J Agric Food Chem. 2011;59(18):9927\u20139934. doi: 10.1021/jf202376u.", "ArticleIdList": ["10.1021/jf202376u", "21870867"]}, {"Citation": "Rajarajan S. Antiviral activity of lyophilized aqueous and ethanolic extracts of Terminalia chebula Retz on hepatitis B virus. Paripex Indian J Res. 2019;8(7):10\u201312."}, {"Citation": "Ralston SH, Penman ID, Strachan MWJ, et al. Davidson\u2019s principles and practice of medicine. 23. Amsterdam: Elsevier; 2018."}, {"Citation": "Sato H, Goto W, Yamamura J, et al. Therapeutic basis of glycyrrhizin on chronic hepatitis B. Antivir Res. 1996;30(2\u20133):171\u2013177. doi: 10.1016/0166-3542(96)00942-4.", "ArticleIdList": ["10.1016/0166-3542(96)00942-4", "8783808"]}, {"Citation": "Shi Y, Li Y, Huang C, et al. Resveratrol enhances HBV replication through activating Sirt1-PGC-1\u03b1-PPAR\u03b1 pathway. Sci Rep. 2016;6(1):24744. doi: 10.1038/srep24744.", "ArticleIdList": ["10.1038/srep24744", "PMC4838842", "27098390"]}, {"Citation": "Shin M, Kang E, Lee Y. A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes. Antivir Res. 2005;67(3):163\u2013168. doi: 10.1016/j.antiviral.2005.06.005.", "ArticleIdList": ["10.1016/j.antiviral.2005.06.005", "16118024"]}, {"Citation": "Shinada M, Azuma M, Kawai H, et al. Enhancement of Interferon-\u03b3 production in Glycyrrhizin-treated human peripheral lymphocytes in response to Concanavalin A and to surface antigen of hepatitis B virus. Proc Soc Exp Biol Med. 1986;181(2):205\u2013210. doi: 10.3181/00379727-181-42241.", "ArticleIdList": ["10.3181/00379727-181-42241", "3080754"]}, {"Citation": "Suresh V, Sojan J, Krishna Radhika N, et al. Anti-HBV activity of the different extracts from Phyllanthus rheedei Wight in cell culture based assay systems. J Ethnopharmacol. 2014;156:309\u2013315. doi: 10.1016/j.jep.2014.08.028.", "ArticleIdList": ["10.1016/j.jep.2014.08.028", "25219604"]}, {"Citation": "Takahara T, Watanabe A, Shiraki K. Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study. J Hepatol. 1994;21(4):601\u2013609. doi: 10.1016/S0168-8278(94)80108-8.", "ArticleIdList": ["10.1016/S0168-8278(94)80108-8", "7814808"]}, {"Citation": "Tandon A. Treatment of subacute hepatitis with Lamivudine and intravenous Glycyrrhizin: a pilot study. Hepatol Res. 2001;20(1):1\u20138. doi: 10.1016/S1386-6346(00)00123-6.", "ArticleIdList": ["10.1016/S1386-6346(00)00123-6", "11282481"]}, {"Citation": "Thyagarajan S, Subramanian S, Thirunalasundari T, et al. Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus. Lancet. 1988 doi: 10.1016/s0140-6736(88)92416-6.", "ArticleIdList": ["10.1016/s0140-6736(88)92416-6", "2901611"]}, {"Citation": "Venkateswaran PS, Millman I, Blumberg BS. Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses In vitro and in vivo studies. Proc Natl Acad Sci. 1987;84(1):274\u2013278. doi: 10.1073/pnas.84.1.274.", "ArticleIdList": ["10.1073/pnas.84.1.274", "PMC304186", "3467354"]}, {"Citation": "Wahyuni TS, Permanasari AA, Aty Widyawaruyanti W, et al. Antiviral activity of Indonesian medicinal plants against Hepatitis B Virus. Pharmacogn J. 2020;12(5):1108\u20131114. doi: 10.5530/pj.2020.12.157.", "ArticleIdList": ["10.5530/pj.2020.12.157"]}, {"Citation": "Waiyaput W, Payungporn S, Issara-Amphorn J, et al. Inhibitory effects of crude extracts from some edible Thai plants against replication of hepatitis B virus and human liver cancer cells. BMC Complement Altern Med. 2012;12(1):1233. doi: 10.1186/1472-6882-12-246.", "ArticleIdList": ["10.1186/1472-6882-12-246", "PMC3553072", "23216691"]}, {"Citation": "Wang LJ, Geng CA, Ma YB, et al. Synthesis, biological evaluation and structure\u2013activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents. Bioorg Med Chem Lett. 2012;22(10):3473\u20133479. doi: 10.1016/j.bmcl.2012.03.081.", "ArticleIdList": ["10.1016/j.bmcl.2012.03.081", "22520261"]}, {"Citation": "Wang CZ, Li WJ, Tao R, et al. Antiviral Activity of a Nanoemulsion of polyprenols from ginkgo leaves against influenza A H3N2 and hepatitis B virus in vitro. Molecules. 2015;20(3):5137\u20135151. doi: 10.3390/molecules20035137.", "ArticleIdList": ["10.3390/molecules20035137", "PMC6272559", "25808155"]}, {"Citation": "Wei W, Li X, Wang K, et al. Lignans with Anti-Hepatitis B Virus activities from Phyllanthus niruri L. Phytother Res. 2012;26(7):964\u2013968. doi: 10.1002/ptr.3663.", "ArticleIdList": ["10.1002/ptr.3663", "22131154"]}, {"Citation": "Wei ZQ, Zhang YH, Ke CZ, et al. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation. World J Gastroenterol. 2017;23(34):6252. doi: 10.3748/wjg.v23.i34.6252.", "ArticleIdList": ["10.3748/wjg.v23.i34.6252", "PMC5603491", "28974891"]}, {"Citation": "World Health Organization. Hepatitis B Fact sheets. 2020. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b Accessed 15 Oct 2020."}, {"Citation": "Wu L, Yang X, Huang Z, et al. In vivo and in vitro antiviral activity of hyperoside extracted from Abelmoschus manihot (L) medik. Acta Pharmacol Sin. 2007;28(3):404\u2013409. doi: 10.1111/j.1745-7254.2007.00510.x.", "ArticleIdList": ["10.1111/j.1745-7254.2007.00510.x", "17303004"]}, {"Citation": "Wu GHM, Boucher BJ, Chiu YH, et al. Impact of chewing betel-nut (Areca catechu) on liver cirrhosis and hepatocellular carcinoma: a population-based study from an area with a high prevalence of hepatitis B and C infections. Public Health Nutr. 2009;12(1):129\u2013135. doi: 10.1017/S1368980008002073.", "ArticleIdList": ["10.1017/S1368980008002073", "18410705"]}, {"Citation": "Xiang Y, Ju H, Li S, et al. Effects of 1,2,4,6-tetra-O-galloyl-\u03b2-D-glucose from P. emblica on HBsAg and HBeAg secretion in HepG2215 cell culture. Virol Sin. 2010;25(5):375\u2013380. doi: 10.1007/s12250-010-3144-y.", "ArticleIdList": ["10.1007/s12250-010-3144-y", "PMC7090425", "20960184"]}, {"Citation": "Xu J, Wang J, Deng F, et al. Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro. Antivir Research. 2008;78(3):242\u2013249. doi: 10.1016/j.antiviral.2007.11.011.", "ArticleIdList": ["10.1016/j.antiviral.2007.11.011", "18313149"]}, {"Citation": "Xu J, Gu W, Li C, et al. Epigallocatechin gallate inhibits hepatitis B virus via farnesoid X receptor alpha. J Nat Med. 2016;70(3):584\u2013591. doi: 10.1007/s11418-016-0980-6.", "ArticleIdList": ["10.1007/s11418-016-0980-6", "26968537"]}, {"Citation": "Yao X, Li J, Deng N, et al. Immunoaffinity purification of \u03b1-momorcharin from bitter melon seeds (Momordica charantia) J Sep Science. 2011;34(21):3092\u20133098. doi: 10.1002/jssc.201100235.", "ArticleIdList": ["10.1002/jssc.201100235", "21994203"]}, {"Citation": "Ye P, Zhang S, Zhao L, et al. Tea polyphenols exerts anti-hepatitis B virus effects in a stably HBV-transfected cell line. J Huazhong Univ Sci Technol Med Sci. 2009;29(2):169\u2013172. doi: 10.1007/s11596-009-0206-1.", "ArticleIdList": ["10.1007/s11596-009-0206-1", "19399398"]}, {"Citation": "Yeh SF, Hong CY, Huang YL, et al. Effect of an extract from Phyllanthus amarus on hepatitis B surface antigen gene expression in human hepatoma cells. Antivir Res. 1993;20(3):185\u2013192. doi: 10.1016/0166-3542(93)90019-F.", "ArticleIdList": ["10.1016/0166-3542(93)90019-F", "8470882"]}, {"Citation": "Zhang L. Randomized clinical trial with two doses (100 and 40 ml) of Stronger Neo-Minophagen C in Chinese patients with chronic hepatitis B. Hepatol Res. 2002;24(3):220\u2013227. doi: 10.1016/S1386-6346(02)00086-4.", "ArticleIdList": ["10.1016/S1386-6346(02)00086-4", "12393023"]}, {"Citation": "Zhao G, Yin Z, Dong J. Antiviral efficacy against hepatitis B virus replication of oleuropein isolated from Jasminum officinale L var grandiflorum. J Ethnopharmacol. 2009;125(2):265\u2013268. doi: 10.7501/j.issn.1674-6384.2013.01.006.", "ArticleIdList": ["10.7501/j.issn.1674-6384.2013.01.006", "19580857"]}, {"Citation": "Zhao G, Yin ZF, Liu LY, et al. Anti-hepatitis B Virus Activity of 8-epi-Kingiside in Jasminum officinale var. grandiflorum. Chinese Herb Med. 2013;5(1):53\u201357. doi: 10.7501/j.issn.1674-6384.2013.01.006.", "ArticleIdList": ["10.7501/j.issn.1674-6384.2013.01.006"]}, {"Citation": "Zhong L, Hu J, Shu W, et al. Epigallocatechin-3-gallate opposes HBV-induced incomplete autophagy by enhancing lysosomal acidification, which is unfavorable for HBV replication. Cell Death Dis. 2015;6(5):e1770\u2013e1770. doi: 10.1038/cddis.2015.136.", "ArticleIdList": ["10.1038/cddis.2015.136", "PMC4669713", "25996297"]}, {"Citation": "Zhou NJ, Geng CA, Huang XY, et al. Anti-hepatitis B virus active constituents from Swertia chirayita. Fitoterapia. 2015;100:27\u201334. doi: 10.1016/j.fitote.2014.11.011.", "ArticleIdList": ["10.1016/j.fitote.2014.11.011", "25447162"]}, {"Citation": "Zuo AX, Shen Y, Jiang ZY, et al. Three new phenolic glycosides from Curculigo orchioides G. Fitoterapia. 2010;81(7):910\u2013913. doi: 10.1016/j.fitote.2010.06.003.", "ArticleIdList": ["10.1016/j.fitote.2010.06.003", "20550957"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "12", "Day": "18"}, {"Year": "2021", "Month": "6", "Day": "12"}, {"Year": "2021", "Month": "10", "Day": "11", "Hour": "6", "Minute": "11"}, {"Year": "2021", "Month": "10", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "12", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "9", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34631974", "PMC8473485", "10.1007/s13337-021-00714-2", "714"]}}], "PubmedBookArticle": []}